Tudor Investment Corp’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-90,270
| Closed | -$544K | – | 1472 |
|
|
2019
Q4 | $544K | Sell |
90,270
-92,168
| -51% | -$555K | 0.02% | 686 |
|
|
2019
Q3 | $657K | Buy |
182,438
+110,879
| +155% | +$399K | 0.02% | 619 |
|
|
2019
Q2 | $192K | Buy |
71,559
+54,531
| +320% | +$146K | 0.01% | 973 |
|
|
2019
Q1 | $50K | Sell |
17,028
-61,734
| -78% | -$181K | ﹤0.01% | 1042 |
|
|
2018
Q4 | $125K | Buy |
78,762
+41,359
| +111% | +$65.6K | ﹤0.01% | 898 |
|
|
2018
Q3 | $138K | Buy |
+37,403
| New | +$138K | ﹤0.01% | 988 |
|
|
2018
Q1 | – | Sell |
-245,820
| Closed | -$708K | – | 1351 |
|
|
2017
Q4 | $708K | Buy |
245,820
+174,952
| +247% | +$504K | 0.02% | 460 |
|
|
2017
Q3 | $318K | Buy |
70,868
+4,165
| +6% | +$18.7K | 0.01% | 797 |
|
|
2017
Q2 | $306K | Sell |
66,703
-22,139
| -25% | -$102K | 0.01% | 750 |
|
|
2017
Q1 | $374K | Sell |
88,842
-106,307
| -54% | -$448K | 0.01% | 852 |
|
|
2016
Q4 | $806K | Buy |
195,149
+92,537
| +90% | +$382K | 0.02% | 456 |
|
|
2016
Q3 | $831K | Buy |
102,612
+82,766
| +417% | +$670K | 0.02% | 459 |
|
|
2016
Q2 | $155K | Sell |
19,846
-20,113
| -50% | -$157K | ﹤0.01% | 1291 |
|
|
2016
Q1 | $308K | Buy |
+39,959
| New | +$308K | 0.01% | 1059 |
|
|
2015
Q3 | – | Sell |
-10,400
| Closed | -$92K | – | 1758 |
|
|
2015
Q2 | $92K | Buy |
+10,400
| New | +$92K | ﹤0.01% | 1381 |
|
|
2015
Q1 | – | Sell |
-13,942
| Closed | -$171K | – | 1675 |
|
|
2014
Q4 | $171K | Sell |
13,942
-31,275
| -69% | -$384K | 0.01% | 1291 |
|
|
2014
Q3 | $451K | Buy |
45,217
+18,625
| +70% | +$186K | 0.02% | 729 |
|
|
2014
Q2 | $201K | Buy |
+26,592
| New | +$201K | 0.01% | 1038 |
|
|
2014
Q1 | – | Sell |
-48,767
| Closed | -$162K | – | 1468 |
|
|
2013
Q4 | $162K | Buy |
+48,767
| New | +$162K | 0.01% | 1123 |
|